Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Nihon Trim Co., Ltd. ( (JP:6788) ).
Nihon Trim reported record third-quarter net sales of 18,345 million yen, up 8.1% year on year, but profits fell at all levels as ordinary profit declined 15.2% to 2,425 million yen and profit attributable to owners of parent dropped 16.2% to 1,560 million yen on higher upfront and operating expenses. Direct sales grew 4.1% to 6,494 million yen, supported by a new color launch and price revisions for its main model and continued focus on sports and beauty markets, while wholesale sales slid 10.3% to 719 million yen even as earlier weakness at existing agents began to recover.
Sales of water purification cartridges rose 3.7% to 4,517 million yen on strong customer follow-up, but SG&A expenses increased due to expanded hiring and heavier advertising and promotion. The bottled water business delivered robust growth with net sales up 31.0% to 3,321 million yen, though profitability is expected to decline as the company boosts advertising to gain market share, and its electrolyzed water hemodialysis business expanded installations to 37 facilities with 1,127 beds, while regenerative medicine subsidiary StemCell Institute Inc. posted a record third-quarter net sales performance despite higher costs from organizational restructuring and human resource investment.
The most recent analyst rating on (JP:6788) stock is a Buy with a Yen5885.00 price target. To see the full list of analyst forecasts on Nihon Trim Co., Ltd. stock, see the JP:6788 Stock Forecast page.
More about Nihon Trim Co., Ltd.
Nihon Trim Co., Ltd., listed on the TSE Prime, operates in the water-related healthcare and medical equipment sector, with core businesses in electrolyzed hydrogen water apparatus, bottled water, electrolyzed water hemodialysis, and regenerative medicine. The company sells through direct and wholesale channels and also generates recurring revenue from water purification cartridges, while expanding into medical and nursing care facilities.
Average Trading Volume: 15,316
Technical Sentiment Signal: Buy
Current Market Cap: Yen39.89B
See more insights into 6788 stock on TipRanks’ Stock Analysis page.